NovaBay Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
NBY 2830 novabay.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - Oct 20th, 2025 5:07 pm
NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value - Sep 23rd, 2025 5:23 pm
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - Sep 18th, 2025 2:30 pm
NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - Aug 26th, 2025 2:05 pm
NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - Aug 19th, 2025 3:25 pm
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Mar 7th, 2025 4:50 am
NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Jan 23rd, 2025 6:00 am
NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why - Dec 25th, 2024 10:00 am
NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - Dec 19th, 2024 4:50 am
NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - Dec 9th, 2024 4:50 am